Skip to main content
European Commission logo print header

Rapid and easy- test for Coronavirus infections

Project description

Novel rapid test for coronavirus detection

The rapid screening of people is one major aspect to controlling the COVID-19 (C-19) pandemic. The diagnostic standard for C-19 testing is RNA detection in swab specimens by RT-PCR, which requires time and specialised personnel. The objective of the EU-funded Corona-Quick project is to develop a rapid, easy, specific and economical screening test for C-19 that will achieve results in less than one hour. The test is developed as a lateral flow strip similar to the pregnancy test and will be used to screen asymptomatic or mildly symptomatic individuals, who pose the greatest risk for community transmission. The project will validate the diagnostic accuracy and screening efficacy of the test with the aim of bringing it to the market within 12 months.


The coronavirus outbreak in 2019 (Cov-19) has challenged the global healthcare system to contain a virus with unprecedented contagious capabilities. A major aspect for controlling the Coronavirus pandemic is the implementation of tools that allow rapid screening of patients at the healthcare centers and not only. Fast and accurate diagnosis of early infections will facilitate the clinical management of the virus, and will improve patients' prognosis. The diagnostic gold standard for Coronavirus is the RNA detection of pharyngeal swab specimen by RT-PCR. However, the limitations of time, need of devices and specialized personnel to perform RT-PCR, combined with the rapid spread and universal susceptibility to the general population, make this diagnostic technique incompatible with the urgent medical needs. Moreover, the number of RT PCR kits available are limited and the production cannot cope with the high demand. The main objective of this study is to develop a rapid, easy and economical screening test for Coronavirus with the capability to achieve results in less than one hour, with high sensitivity and specificity. The test will be used to screen asymptomatic or mildly symptomatic individuals, which can risk community transmission to population categories at a higher risk (elderly with underlying conditions, among others). Corona-Test is a lateral flow strip test similar to the well-known pregnancy test. Herein, we are aiming to validate the diagnostic accuracy and screening efficacy of Corona-Test. This strategy could provide the means to prevent and control the disease. The objective of this project will be to bring two different applications of the test to market within 20 months.


Call for proposal


See other projects for this call

Sub call




Net EU contribution
€ 1 439 900,00
Paseo mikeletegi 83 3
20009 Donostia san sebastian

See on map


The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Noreste País Vasco Gipuzkoa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 1 134 850,00